Partnering with us to develop your first-in-class pipeline with advanced modalities such as CRSPR, epigenetic factors, mRNAs, siRNAs, micro RNAs and others. 

​

We deliver your payloads precisely to the desired disease site, even some that never been reached before.

 

We are particularly interested in partnership in cardiovascular, CNS, kidney diseases and immuno-oncology.